Search / Trial NCT06230744

A Novel Intervention for Weight Loss in Young Adults

Launched by UNIVERSITY OF CHICAGO · Jan 19, 2024

Trial Information

Current as of October 04, 2024

Recruiting

Keywords

Description

The study team is seeking volunteers to participate in a research study to help better understand how a behavioral intervention combined with technology may impact weight loss. Participation will span approximately 6 months. Participants will be required to attend up to 5 visits at the University of Chicago. Those visits will include daytime visits to a clinic involving fasted blood draws and completion of surveys. During the study, participants will regularly record their weight using a digital scale, input their daily food intake into a smartphone app, and wear a wrist activity monitor to...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Overweight or obese (BMI 25.5- 34.9 kg/m2) men and women
  • * Ages 18 to 40 years
  • * Weight stable (no change \>25 lbs in the past 3 months)
  • * Owns a smartphone and willing to install the study app
  • Exclusion Criteria:
  • * Presence of obstructive sleep apnea or history of any other sleep disorder.
  • * Irregular menses, menopausal symptoms or post-menopausal, currently pregnant, trying to get pregnant or nursing
  • * Regular travel across time zones
  • * Subjects who are currently following a weight loss regimen or any other special diet or exercise programs
  • * Increased fractional lean body mass (e.g., athletes)
  • * Unable to walk, using an assistive device for mobility, or any contraindications to exercise
  • * Diabetes
  • * Claustrophobia
  • * Excessive alcohol (\>2 drinks/day) or caffeine (\>300mg/day) intake, regular nicotine use, substance abuse.
  • * Abnormal findings on screening blood testing.
  • * Participants taking any prescription, over-the-counter drugs/supplements that can affect sleep or weight.
  • * Major psychiatric or any eating disorder, and any acute or chronic medical condition that increase the risk of interventions (e.g., heart disease)
  • * Any underlying disease likely to limit life span and/or increase risk of interventions including cardiovascular disease (e.g. unstable angina, heart failure requiring hospitalization in the past 6 months, significant heart block or arrhythmias, NYHA Class\>2), pulmonary disease with dependence on oxygen or daily use of bronchodilators, cancer requiring treatment in the past 5 years unless the prognosis is considered good, active or chronic infection, thyroid disease and other endocrine disorders (e.g. Cushing syndrome, acromegaly), hepatitis or other chronic gastrointestinal disease (pancreatitis, inflammatory bowel disease), renal disease, significant anemia, recent surgery or significant abdominal surgery, major psychiatric or any eating disorder, acute coronary syndrome or stroke in the past 6 months

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Chicago, Illinois, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0